In the last trading session, 5.43 million Cano Health Inc. (NYSE:CANO) shares changed hands as the company’s beta touched 0. With the company’s per share price at $13.81 changed hands at -$0.19 or -1.36% during last session, the market valuation stood at $6.23B. CANO’s last price was a discount, traded about -26.21% off its 52-week high of $17.43. The share price had its 52-week low at $9.20, which suggests the last value was 33.38% up since then. When we look at Cano Health Inc.’s average trading volume, we note the 10-day average is 4.98 million shares, with the 3-month average coming to 2.82 million.
Analysts gave the Cano Health Inc. (CANO) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CANO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Cano Health Inc.’s EPS for the current quarter is expected to be -$0.01.
Cano Health Inc. (NYSE:CANO) trade information
Instantly CANO was in red as seen at the end of in last trading. With action 2.37%, the performance over the past five days has been green. The drop to weekly highs of 14.33 on Monday, 09/13/21 subtracted -1.36% to the stock’s daily price. The company’s shares are showing year-to-date upside of 2.98%, with the 5-day performance at 2.37% in the green. However, in the 30-day time frame, Cano Health Inc. (NYSE:CANO) is 16.44% up.
The consensus price target for the stock as assigned by Wall Street analysts is $19.33, meaning bulls need an upside of 28.56% from its current market value. According to analyst projections, CANO’s forecast low is $18.00 with $22.00 as the target high. To hit the forecast high, the stock’s price needs a -59.3% plunge from its current level, while the stock would need to soar -30.34% for it to hit the projected low.
Cano Health Inc. (CANO) estimates and forecasts
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $435.67 million. 2 analysts are of the opinion that Cano Health Inc.’s revenue for the quarter ending Dec 2021 will be $468.12 million.
Cano Health Inc. is expected to release its next quarterly earnings report in October.
Cano Health Inc. (NYSE:CANO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.93% of Cano Health Inc. shares while 42.01% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 43.28%.